Prime Highlights:  A dozen drugmakers are developing new weight-loss treatments that prioritize muscle mass preservation alongside fat reduction.  Drugs like Novo Nordisk’s Wegovy and Eli

Prime Highlights:  Tuberculosis (TB) continues to affect millions globally, with rising concerns over drug-resistant strains.  A groundbreaking study uses artificial intelligence (AI) to accelerate the

Prime Highlights:  Germany’s Merck KGaA is negotiating to acquire U.S. biotech firm SpringWorks Therapeutics, specializing in cancer and rare disease treatments.  SpringWorks has a market

Prime Highlights:  Eli Lilly plans to release late-stage trial data for Retatrutide in 2025, ahead of the previous 2026 estimate.  The study will focus on

Key highlights:  Spotlight on emerging Technologies  AI-driven Innovation with Dolffia  Industry Whitepaper Release  NTT DATA attended the DIA Europe 2024. The event is an International

Key Highlights: • $2.5 Million Grant to Expand Testing in Kenya • Significant Improvement in Pediatric Cancer Survival • Scaling Up Testing and Research Efforts

Key Highlights:  High Performance Infrared Imaging  AI-powered Data Evaluation and Multi-modal imaging  Versatile and customizable for Research Needs  Bruker launched LUMOS II ILIM Infrared Imaging

Prime Highlights:  Noel, who has been with UnitedHealthcare since 2007, previously led the Medicare and Retirement division and brings a wealth of experience to the

Prime Highlights: The company’s stock rose significantly after promising results from an early-stage trial of amycretin, a new weight-loss drug. Participants in the trial lost

Prime Highlights: M42, the Middle East's largest healthcare company, introduces a new operational structure to enhance its global presence, with 480 clinics across 26 countries.